Christine M Eischen

10PUBLICATIONS
41CO-AUTHORS
AutoimmunityHaematologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 20, 2025
TLR2 agonism suppresses myeloid leukemogenesis by reprogramming leukemia stem cells.

Michael E Lawler, Jennifer S Romer-Seibert, Michael S Bowman

|Jul 24, 2024
DNA fork remodeling proteins, Zranb3 and Smarcal1, are uniquely essential for aging hematopoiesis.

Saul Kushinsky, Matthew V Puccetti, Clare M Adams

|Dec 08, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams

|Jun 28, 2023
Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs.

Ramkrishna Mitra, Clare M Adams, Christine M Eischen

|Feb 03, 2023
Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer.

Clare M Adams, Ramkrishna Mitra, Youcai Xiao

Pageof 2